These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29030082)

  • 41. Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.
    Rook JM; Xiang Z; Lv X; Ghoshal A; Dickerson JW; Bridges TM; Johnson KA; Foster DJ; Gregory KJ; Vinson PN; Thompson AD; Byun N; Collier RL; Bubser M; Nedelcovych MT; Gould RW; Stauffer SR; Daniels JS; Niswender CM; Lavreysen H; Mackie C; Conde-Ceide S; Alcazar J; Bartolomé-Nebreda JM; Macdonald GJ; Talpos JC; Steckler T; Jones CK; Lindsley CW; Conn PJ
    Neuron; 2015 May; 86(4):1029-1040. PubMed ID: 25937172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade.
    Stefani MR; Moghaddam B
    Eur J Pharmacol; 2010 Aug; 639(1-3):26-32. PubMed ID: 20371234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits.
    Thomas JD; Garcia GG; Dominguez HD; Riley EP
    Psychopharmacology (Berl); 2004 Sep; 175(2):189-95. PubMed ID: 15064913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
    Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
    Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation.
    Cippitelli A; Damadzic R; Frankola K; Goldstein A; Thorsell A; Singley E; Eskay RL; Heilig M
    Biol Psychiatry; 2010 May; 67(9):823-30. PubMed ID: 20132926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emotional Impairment and Persistent Upregulation of mGlu5 Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction.
    Zanos P; Georgiou P; Gonzalez LR; Hourani S; Chen Y; Kitchen I; Kieffer BL; Winsky-Sommerer R; Bailey A
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26861145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of group I mGlu receptors in the expression of ethanol-induced conditioned place preference and ethanol withdrawal seizures in rats.
    Kotlinska JH; Bochenski M; Danysz W
    Eur J Pharmacol; 2011 Nov; 670(1):154-61. PubMed ID: 21946112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator.
    Gastambide F; Cotel MC; Gilmour G; O'Neill MJ; Robbins TW; Tricklebank MD
    Neuropsychopharmacology; 2012 Mar; 37(4):1057-66. PubMed ID: 22129780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prefrontal Cortex K
    Cannady R; McGonigal JT; Newsom RJ; Woodward JJ; Mulholland PJ; Gass JT
    J Neurosci; 2017 Apr; 37(16):4359-4369. PubMed ID: 28320841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic intermittent ethanol exposure leads to alterations in brain-derived neurotrophic factor within the frontal cortex and impaired behavioral flexibility in both adolescent and adult rats.
    Fernandez GM; Lew BJ; Vedder LC; Savage LM
    Neuroscience; 2017 Apr; 348():324-334. PubMed ID: 28257889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The infralimbic cortex and mGlu5 mediate the effects of chronic intermittent ethanol exposure on fear learning and memory.
    Smiley CE; McGonigal JT; Valvano T; Newsom RJ; Otero N; Gass JT
    Psychopharmacology (Berl); 2020 Nov; 237(11):3417-3433. PubMed ID: 32767063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.
    Rook JM; Tantawy MN; Ansari MS; Felts AS; Stauffer SR; Emmitte KA; Kessler RM; Niswender CM; Daniels JS; Jones CK; Lindsley CW; Conn PJ
    Neuropsychopharmacology; 2015 Feb; 40(3):755-65. PubMed ID: 25241804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone.
    Cippitelli A; Domi E; Ubaldi M; Douglas JC; Li HW; Demopulos G; Gaitanaris G; Roberto M; Drew PD; Kane CJM; Ciccocioppo R
    Brain Behav Immun; 2017 Aug; 64():320-329. PubMed ID: 28167117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficits in the extinction of ethanol-seeking behavior following chronic intermittent ethanol exposure are attenuated with positive allosteric modulation of mGlu5.
    Gass JT; McGonigal JT; Chandler LJ
    Neuropharmacology; 2017 Feb; 113(Pt A):198-205. PubMed ID: 27725153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism.
    Isherwood SN; Pekcec A; Nicholson JR; Robbins TW; Dalley JW
    Psychopharmacology (Berl); 2015 Sep; 232(18):3327-44. PubMed ID: 26063678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethanol attenuates spatial memory deficits and increases mGlu1a receptor expression in the hippocampus of rats exposed to prenatal stress.
    Van Waes V; Enache M; Zuena A; Mairesse J; Nicoletti F; Vinner E; Lhermitte M; Maccari S; Darnaudéry M
    Alcohol Clin Exp Res; 2009 Aug; 33(8):1346-54. PubMed ID: 19413649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.
    Kjaerby C; Bundgaard C; Fejgin K; Kristiansen U; Dalby NO
    Neuropharmacology; 2013 Sep; 72():157-68. PubMed ID: 23643744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling.
    Noetzel MJ; Gregory KJ; Vinson PN; Manka JT; Stauffer SR; Lindsley CW; Niswender CM; Xiang Z; Conn PJ
    Mol Pharmacol; 2013 Apr; 83(4):835-47. PubMed ID: 23348500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists.
    Lamb JP; Engers DW; Niswender CM; Rodriguez AL; Venable DF; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2011 May; 21(9):2711-4. PubMed ID: 21183344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.